Within two days of the Federal Trade Commission (FTC) finalizing its new rule banning noncompetes nationwide to open the door for up to $488 billion in increased worker earnings over the next decade, the agency is already facing lawsuits from right-wing special interests in two Texas federal courts that both fall under the jurisdiction of the conse
MAGA members of Congress, extremist group leaders gather with international allies to plot next steps of far-right agenda
Bristol Meyer Squibb, AstraZeneca, and Merck—three pharmaceutical giants suing to stop the Biden administration from lowering drug prices through the Inflation Reduction Act—posted $40.33 billion in combined Q1 2024 revenue today. Earlier this week government watchdog Accountable.US spotlighted excessive spending and lobbying by the pharmaceutical
The corporate-funded U.S. Chamber of Commerce has officially sued the Federal Trade Commission (FTC) today over its new rule banning noncompetes nationwide which will safeguard the right of workers to seek better opportunities and open the door for up to $488 billion in increased worker earnings over the next decade, or an estimated $524 in earning
Kavanaugh's pre-SCOTUS statements under scrutiny as Supreme Court oral arguments loom
Today, the Federal Trade Commission (FTC) announced its final rule banning noncompetes nationwide, safeguarding the right of workers across the country to seek new opportunities and opening the door for up to $488 billion in increased worker earnings over the next decade, or an estimated $524 in earnings for the average employee per year.
An Accountable.US review of new corporate political spending data from the Federal Election Commission found that in March 2024 alone big bank trade groups gave $36,000 to Republican U.S. Senators who weeks later co-sponsored a Congressional Review Act Resolution to kill the Consumer Financial Protection Bureau’s (CFPB) popular new rule capping cre
Today, Accountable.US released the following statement on the disclosures of record-breaking lobbying and spending by the pharmaceutical industry in the first quarter of 2024. The massive spending by Big Pharma comes as they attempt to buy influence in the hopes of rolling back President Biden’s historic new program to allow Medicare to finally
Judicial Ethics Enforcement Act is critical step toward restoring SCOTUS credibility, integrity
Get the latest news on how we’re holding big business, government officials, and special interests accountable, and what you can do to get involved.
By submitting your cell phone number you are agreeing to receive periodic text messages from this organization. Message and data rates may apply. Text HELP for more information. Text STOP to stop receiving messages.
